Trump’s trade war could raise Australian medicine costs and limit availability, complicating PBS negotiations and tariff impacts.
In Short
Concerns arise in Australia over a US-Australia trade dispute affecting medicine costs and the Pharmaceutical Benefits Scheme. Potential US tariffs could…
Click here to view the original article.